Viewing Study NCT00016094


Ignite Creation Date: 2025-12-25 @ 1:41 AM
Ignite Modification Date: 2026-01-03 @ 7:49 AM
Study NCT ID: NCT00016094
Status: COMPLETED
Last Update Posted: 2013-01-29
First Post: 2001-05-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: S0108 Bevacizumab in Treating Patients With Non-Hodgkin's Lymphoma
Sponsor: National Cancer Institute (NCI)
Organization:

Organization Data

Organization:
Class: NIH
Study ID: NCI-2012-03039
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators